Rybelsus OverviewSemaglutide, sold under the brand names Ozempic and Rybelsus, is an anti-diabetic medication used for the treatment of type 2 diabetes. Semaglutide acts like human glucagon-like peptide-1 (GLP-1) so that it increases insulin secretion, thereby increasing sugar metabolism. It is distributed as a metered subcutaneous injection in a prefilled pen. One of its advantages over other antidiabetic drugs is that it has a long duration of action, thus, only once-a-...
Read more Rybelsus Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Semaglutide
Recent Rybelsus Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Solution: 2mg/1.5ml (1.34mg/ml), 4mg/3ml (1.34mg/ml)
- Tablet: 14mg, 3mg, 7mg
NDC Database Records for Rybelsus: (3 results)Sorted by National Drug Code
- 0169-4303 Rybelsus 3 mg Oral Tablet by Novo Nordisk
- 0169-4307 Rybelsus 7 mg Oral Tablet by Novo Nordisk
- 0169-4314 Rybelsus 14 mg Oral Tablet by Novo Nordisk